Breed Update Newsletter

 Breeder Updates Newsletter
The Purina® Pro Plan® Breed Update newsletters cover the latest research advances in canine health and genetics for specific dog breeds, plus there is a general dog newsletter. Explore our archive of articles or use the filters to access specific information.

Dog Articles

View
Filter
43 Results
Edit
By Species
By Awards & Recognitions
By Affiliation
Breeding healthy dogs entails applying selective pressure to decrese the number of deleterious disese liability genes and improve the probability of healthy genes. There are many tools today available to help breeders make the best decisions to help
A fatal neurological disease affecting young Rottweiler dogs, juvenile-onset laryngeal paralysis and polyneuropathy (JLPP) is caused by an autosomal recessive mutation in the RAB3GAP1 gene. Affected dogs typically show signs of general weakness
Eye diseases in Poodles have long been a health concern. Despite efforts to encourage eye tests and advise breeders to selectively breed against eye diseases, one expert notes an ongoing steady increase in Poodle eye diseases.
Advances treating canine diseases, such as cancer, often come from innovative studies patterned after human medicine. New therapies using checkpoint molecules and personalized medicine for canine mast cell tumor provide a promising future.
Lafora disease in Miniature Wirehaired Dachshunds is a late-onset progressive myoclonic epilepsy that occurs around 7 years of age. The disease occurred in dogs in the U.K. for decades before the autosomal recessive gene mutation was discovered
Boxers are among the breeds with an increased risk for mast cell tumor, the most common skin cancer in dogs. Mast cells are an important part of the immune system, but when they replicate out of control, they form an aggressive cancer.
A newly adapted gastric decompression technique may help save lives of German Shepherd dogs. Learn more about the G-cath technique at Purina Pro Club.
Beagles are among the breeds considered predisposed to developing steroid-responsive meningitis-arteritis (SRMA), an immune-mediated neurological disorder. Although the condition is generally treated successfully, it is not readily recognized. A rece